Two years ago, Sangeeta Bhatia and Christopher Chen founded a biotech company that on Wednesday officially launched as Satellite Bio in Cambridge, Massachusetts. The company aims to translate the work of Bhatia, Chen and their cofounder Arnav Chhabra into "tissue therapeutics" — regenerative medicines built from bioengineered tissue structures, or "satellites," that can be implanted into patients. Source: BiopharmaDive
Explore more about: Liver Disease
April 21, 2022
August 6, 2021
3D bioprinted algae can be harnessed as a sustainable source of oxygen for human cells in engineered vascularized tissues, researchers report. They embedded the bioprinted photosynthetic algae, along with human liver-derived cells, in a 3D hydrogel matrix to create honeycomb-shaped tissues with lobules, similar to the human liver.
May 3, 2022
New research has more than tripled the amount of time human livers can be stored for transplantation. Scientists have modified a previous protocol to extend the viability of rat livers and successfully applied it to human livers.
June 29, 2021
Bioengineers have developed a 3D printing technique that creates the interacting networks for transport of air, blood, and other bodily fluids—a major step toward 3D printed replacement organs.
October 2, 2019
A team of researchers have created a 'liver on a chip,' a model of liver tissue that replicates the metabolic variations found throughout the organ.